<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04010851</url>
  </required_header>
  <id_info>
    <org_study_id>2018/1196/REK Mid Norway</org_study_id>
    <nct_id>NCT04010851</nct_id>
  </id_info>
  <brief_title>The Effects of a Peer Co-led Educational Programme for Parents of Children With ADHD</brief_title>
  <acronym>ADHD</acronym>
  <official_title>The Effects of a Peer Co-led Educational Programme for Parents of Children With ADHD: A Feasibility Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Molde University College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      ADHD is associated with a substantial burden on families, and systems pertaining to health,
      social care, and criminal justice, and there is a need for more knowledge of the effects of
      non-pharmacological interventions. Educational and parental activation interventions may
      improve ADHD symptoms, and may enhance parent activation. Although the results of these
      studies are promising, few interventions have been carried out in collaboration with user
      representatives, which is required by Norwegian legislation. As such, there is a need for
      clinical studies that document the effects of educational group interventions based on user
      involvement that seeks to improve parental activation. Furthermore, it is not clear which
      type of educational intervention that should be offered, and which aspects of parenting
      behaviour to focus on. There is a lack of studies investigating whether adding an
      intervention designed specifically for families of children with ADHD will be more effective
      than treatment as usual (TAU). The purpose of the present study is to determine the
      feasibility and expected size of a substantive randomized controlled trial comparing an ADHD
      peer co-led educational programme added to TAU.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this trial is to evaluate the acceptability and feasibility of the
      intervention, to assure that procedures are adequate for a subsequent full size randomized
      controlled trial (RCT), and to determine the likely size of the trial comparing an ADHD
      specific parenting peer co-led intervention for parents of children with ADHD symptoms.

      Specific objectives are:

      (I) investigate whether parents of children recently diagnosed with ADHD are willing to be
      randomized to the intervention, (II) whether sufficient numbers of families can be recruited
      and retained such that a full-scale RCT is likely to be feasible, (III) whether research
      procedures and efficacy measures are feasible and acceptable to participating families and
      the outpatient clinics, and (IV) whether families participating in the intervention are
      satisfied with the intervention.

      This feasibility study is not designed to detect a treatment effect, therefore a maximum of
      50 parents will be recruited. The measurements will be taken in the children (at baseline and
      3 months) and parents (at baseline, two weeks, pre-post intervention and 3 months follow-up)
      to determine the feasibility and acceptability. These measures are chosen because they
      address key components of the intervention (activation, quality of life and psychological
      well-being). Multiple measures of similar constructs will be administered where possible
      (e.g., psychological well-being and quality of life) to determine which measure to include in
      the definitive trial according to feasibility, acceptability, and sensitivity.

      Feasibility assessments:

        -  Feasibility of recruitment.

        -  Acceptability of randomization and procedures will be determined by measuring loss to
           follow-up (post-test and 3-month follow-up), and reasons for withdrawal will be used
           collected.

        -  Acceptability of the intervention will be determined based on the number of sessions
           attended by participants in the peer co-led education. We will also reported on
           satisfaction with the program.

        -  Feasibility of quantitative measures will be deemed acceptable if no questionnaires are
           missing in full in more than 25% of the participants and if reliability was higher than
           0.70.

        -  Follow-up response rates (post-intervention and 3 months follow-ups).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2020</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The intervention is delivered in a group format, which takes the form of a full day's training, focusing on ADHD diagnosis, its treatment, how to cope with the challenges related to living with ADHD, as well as coping with challenges of parenting a child with chronic health conditions. After this one day-intervention, the participants can continue in self-help groups, which meet once a week for a 2-hour evening session. User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence. Participants are encouraged to adopt an active role in order to achieve a positive parent/provider partnership.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of recruitment</measure>
    <time_frame>Over a two year study period</time_frame>
    <description>Feasibility of recruitment will be assessed by determining the recruitment rate, by monitoring patient screening and subsequent agreement to participate.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Satisfaction with the intervention</measure>
    <time_frame>From baseline to 12- and 52-weeks follow-up</time_frame>
    <description>Parent satisfaction will be measured by means of the client satisfaction Questionnaire, CSQ-3 as it applies to the group-based educational programme. The scale comprises three items measured on a scale from 1 (not satisfied) to 4 (very satisfied).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Parental activation</measure>
    <time_frame>From baseline to 12- and 52-weeks follow-up</time_frame>
    <description>Parental activation will be measure with the P-PAM-13. The 13-items P-PAM has four possible response options ranging from (1) strongly disagree, to (4) strongly agree, and an additional 'not applicable' option.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Parental well-being</measure>
    <time_frame>From baseline to 12- and 52-weeks follow-up</time_frame>
    <description>Parental well-being will be measured by the WHO-5 Well-being Index. The questionnaire has five items rated on a six-point scale from 0 (all the time) to 5 (at no time); this items are transformed into 0-100 scales (high scores indicate a better well-being).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parental quality of life</measure>
    <time_frame>From baseline to 12- and 52-weeks follow-up</time_frame>
    <description>Parental quality of life will be measured by the 10- items Multicultural Quality of Life Index (MQLI) which cover key aspects of the concept, from physical well-being to spiritual fulfilment. The MQLI questionnaire has ten items.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shared decision making</measure>
    <time_frame>From baseline to 12- and 52-weeks follow-up</time_frame>
    <description>It will be assessed using a modified version of the Control Preferences Scale to provide information about the parent's preferred role in involvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parental involvement in treatment decision</measure>
    <time_frame>From baseline to 12- and 52-weeks follow-up</time_frame>
    <description>Parent involvement will be assessed using a modified version of the CollaboRATE scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beliefs about medicines</measure>
    <time_frame>From baseline to 12- and 52-weeks follow-up</time_frame>
    <description>To investigate the beliefs about medicines we will use the Beliefs about Medicines Questionnaire (BMQ).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence</measure>
    <time_frame>From baseline to 12- and 52-weeks follow-up</time_frame>
    <description>To investigate medication adherence using the Medication Adherence Rating Scale 5 items.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ADHD Scale Parent Version</measure>
    <time_frame>From baseline to 12- and 52-weeks follow-up</time_frame>
    <description>The SNAP-IV 18-Item will be use to evaluate ADHD, the SNAP-IV 18-Item Scale Parent Version is an abbreviated version of the Swanson, Nolan, and Pelham (SNAP). The questionnaire includes items for the two subsets of symptoms, inattention (items 1-9) and hyperactivity/impulsivity (items 10-18), from the DSM-IV criteria for ADHD. The scores in each of the two subsets are added together. SNAP-IV is used to measure ADHD symptoms and behavioral problems in school-aged children. Symptom severity is rated on a 4-point scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of functioning of children in Child</measure>
    <time_frame>From baseline to 12- and 52-weeks follow-up</time_frame>
    <description>The C-GAS will be used to assess the overall level of functioning of children. The C-GAS is a numeric scale ranging from 1 to 100 used to assess the overall level of functioning of children in Child and Adolescent Mental Health Services, with high scores indicating better functioning.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Participation in treatment</measure>
    <time_frame>From baseline to 12- and 54-weeks follow-up.</time_frame>
    <description>Information regarding treatment participation and use of services will be collected via Patient Administrative System (PAS).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Attention Deficit Disorder With Hyperactivity</condition>
  <arm_group>
    <arm_group_label>Peer co-led educational group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention delivered in a group format is added to treatment as usual. After the parents participate in the one day-intervention, they can continue in self-help groups, which meet once a week for a 2-hour evening session. User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The control goup will receive treatment as usual.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Peer co-led educational group</intervention_name>
    <description>The intervention is delivered in a group format, which takes the form of a full day's training, focusing on ADHD diagnosis, its treatment, how to cope with the challenges related to living with ADHD, as well as coping with challenges of parenting a child with chronic health conditions. After this one day-intervention, the participants can continue in self-help groups, which meet once a week for a 2-hour evening session. User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence. Participants are encouraged to adopt an active role in order to achieve a positive parent/provider partnership.</description>
    <arm_group_label>Peer co-led educational group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Comparator treatment as usual</intervention_name>
    <description>Control group will receive treatment as usual, including different treatment options that can help alleviate the symptoms of ADHD and arm families with the tools needed to better handle problem behaviors when they arise. These interventions include: medication, psychotherapy, or a combination of these two approaches.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parents of children aged 6 - 12 with a formal diagnosis of ADHD, following a
             standardised assessment.

        Exclusion Criteria:

          -  Participants already taking part in research on a parenting intervention will also be
             ineligible to participate.

          -  Families attending other parenting groups
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingunn P. Mundal, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Molde University College</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mariela Loreto Lara Cabrera, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Olavs Hospital, Department of research and development AFFU, and NTNU</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rolf W. Gr√•we, Phd prof</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ingunn P. Mundal, PhD</last_name>
    <phone>004792668499</phone>
    <email>ingunn.mundal@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mariela Loreto Lara Cabrera, PhD</last_name>
    <phone>004748280188</phone>
    <email>mariela.lara@ntnu.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <contact>
      <last_name>Mariela Loreto L Lara Cabrera, phd</last_name>
      <email>mariela.lara@ntnu.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>June 28, 2019</study_first_submitted>
  <study_first_submitted_qc>July 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2019</study_first_posted>
  <last_update_submitted>May 11, 2020</last_update_submitted>
  <last_update_submitted_qc>May 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parental activation</keyword>
  <keyword>Peer co-led education</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We anticipate that anonymised trial data may be shared with other researchers to enable international prospective meta-analyses.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

